EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A + Dravet syndrome: Insights from the ENVISION natural history study

M Scott Perry iD, Ingrid E Scheffer iD, Joseph Sullivan, Andreas Brunklaus iD, Susana Boronat, James W Wheless, Linda Laux, Anup D Patel iD, Colin M Roberts, Dennis Dlugos, Deborah Holder, Kelly G Knupp iD und 17 weitere

Epilepsia · 2024-02 · 65 (2) · 322-337

DOI: 10.1111/epi.17850 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Epilepsia, online erschienen am 22.12.2023. Verfasst von M Scott Perry und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cook Children's Medical Center, Fort Worth, Texas, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Encoded Therapeutics, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dravet syndrome (DS) is a developmental and epileptic encephalopathy characterized by high seizure burden, treatment‐resistant epilepsy, and developmental stagnation. Family members rate communication deficits among the most impactful disease manifestations. We evaluated seizure burden and language/communication development in children with DS.

Methods

ENVISION was a prospective, observational study evaluating children with DS associated with SCN1A pathogenic variants ( SCN1A + DS) enrolled at age ≤5 years. Seizure burden and antiseizure medications were assessed every 3 months and communication and language every 6 months with the Bayley Scales of Infant and Toddler Development 3rd edition and the parent‐reported Vineland Adaptive Behavior Scales 3rd edition. We report data from the first year of observation, including analyses stratified by age at Baseline: 0:6–2:0 years:months (Y:M; youngest), 2:1–3:6 Y:M (middle), and 3:7–5:0 Y:M (oldest).

Results

Between December 2020 and March 2023, 58 children with DS enrolled at 16 sites internationally. Median follow‐up was 17.5 months (range = .0–24.0), with 54 of 58 (93.1%) followed for at least 6 months and 51 of 58 (87.9%) for 12 months. Monthly countable seizure frequency (MCSF) increased with age (median [minimum–maximum] = 1.0 in the youngest [1.0–70.0] and middle [1.0–242.0] age groups and 4.5 [.0–2647.0] in the oldest age group), and remained high, despite use of currently approved antiseizure medications. Language/communication delays were observed early, and developmental stagnation occurred after age 2 years with both instruments. In predictive modeling, chronologic age was the only significant covariate of seizure frequency (effect size = .52, p = .024). MCSF, number of antiseizure medications, age at first seizure, and convulsive status epilepticus were not predictors of language/communication raw scores. Significance In infants and young children with SCN1A + DS, language/communication delay and stagnation were independent of seizure burden. Our findings emphasize that the optimal therapeutic window to prevent language/communication delay is before 3 years of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicInfantHumansChild, PreschoolInfant, NewbornProspective StudiesMutationSeizuresNAV1.1 Voltage-Gated Sodium ChannelCommunication

Stichwörter der Autor:innen

Dravet syndromeENVISIONcommunication/language delaysdevelopmental and epileptic encephalopathynatural history study

Substanzen

NAV1.1 Voltage-Gated Sodium ChannelSCN1A protein, human

Autor:innen und Institutionen

  • Cook Children's Medical Center, Fort Worth, Texas, USA.
  • University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
  • University of California, San Francisco, San Francisco, California, USA.
  • School of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Le Bonheur Children's Hospital, Memphis, Tennessee, USA.

ORCID-Profile: M Scott Perry, Ingrid E Scheffer, Andreas Brunklaus, Anup D Patel, Kelly G Knupp, Dennis Lal, Elaine Wirrell, Maria Candida Vila, Jacqueline S Gofshteyn, Salvador Rico

Förderung

  • Encoded Therapeutics, Inc.

Zitieren

APA

Perry, M. S., Scheffer, I. E., Sullivan, J., Brunklaus, A., Boronat, S., Wheless, J. W., Laux, L., Patel, A. D., Roberts, C. M., Dlugos, D., Holder, D., Knupp, K. G., Lallas, M., Phillips, S., Segal, E., Smeyers, P., Lal, D., Wirrell, E., Zuberi, S., …, & Rico, S. (2024). Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A + Dravet syndrome: Insights from the ENVISION natural history study. Epilepsia, 65(2), 322-337. https://doi.org/10.1111/epi.17850

Vancouver

Perry MS, Scheffer IE, Sullivan J, Brunklaus A, Boronat S, Wheless JW, et al. Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A + Dravet syndrome: Insights from the ENVISION natural history study. Epilepsia. 2024;65(2):322-337. doi:10.1111/epi.17850

BibTeX
@article{Perry2024,
  author = {Perry, M Scott and Scheffer, Ingrid E and Sullivan, Joseph and Brunklaus, Andreas and Boronat, Susana and Wheless, James W and Laux, Linda and Patel, Anup D and Roberts, Colin M and Dlugos, Dennis and Holder, Deborah and Knupp, Kelly G and Lallas, Matt and Phillips, Steven and Segal, Eric and Smeyers, Patricia and Lal, Dennis and Wirrell, Elaine and Zuberi, Sameer and Brünger, Tobias and Wojnaroski, Mary and Maru, Benit and O'Donnell, Penrose and Morton, Magda and James, Emma and Vila, Maria Candida and Huang, Norman and Gofshteyn, Jacqueline S and Rico, Salvador},
  title = {Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A + Dravet syndrome: Insights from the ENVISION natural history study},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {2},
  pages = {322--337},
  doi = {10.1111/epi.17850}
}
Kostenlos starten →